These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis. Geller DE, Madge S. Respir Med; 2011 Dec; 105 Suppl 2():S24-31. PubMed ID: 22208547 [Abstract] [Full Text] [Related]
16. Respiratory therapies in the critical care setting. Should aerosolized antibiotics be administered to prevent or treat ventilator-associated pneumonia in patients who do not have cystic fibrosis? MacIntyre NR, Rubin BK. Respir Care; 2007 Apr; 52(4):416-21; discussion 421-2. PubMed ID: 17417976 [Abstract] [Full Text] [Related]
17. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis]. Caramia G, Gagliardini R, Rocchi AL, Palumbo P. Minerva Pediatr; 1986 Jul 31; 38(13-14):569-78. PubMed ID: 3528799 [No Abstract] [Full Text] [Related]
18. [Bacterial infections and resistance to antibiotics in cystic fibrosis]. Taccetti G, Repetto T, Procopio E, Marianelli L, Campana S. Pediatr Med Chir; 1999 Jul 31; 21(5 Suppl):213-8. PubMed ID: 10963010 [Abstract] [Full Text] [Related]
19. Delivery of antibiotics to the respiratory tract: an update. Traini D, Young PM. Expert Opin Drug Deliv; 2009 Sep 31; 6(9):897-905. PubMed ID: 19637984 [Abstract] [Full Text] [Related]
20. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Hoffmann IM, Rubin BK, Iskandar SS, Schechter MS, Nagaraj SK, Bitzan MM. Pediatr Pulmonol; 2002 Nov 31; 34(5):375-7. PubMed ID: 12357482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]